Evidence map›Paper›PMID 19048400›Full record

ArticlePathology oncology research : POR2009

Gammaaminobutyric acid A receptor alpha 3 subunit is overexpressed in lung cancer.

Yan Liu, Fengjie Guo, Miao Dai, Di Wang, Yongqing Tong, Jian Huang, Jinyue Hu, Guancheng Li

Abstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Cancer and neurotransmitter receptors.Chinese medical journal · 2025
    Review
  4. Therapeutically leveraging GABAExperimental biology and medicine (Maywood, N.J.) · 2021
    Review
  5. GABAIUPHAR/BPS guide to pharmacology CITE · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yan LiuTumor Immunobiology Laboratory of Cancer Research Institute, Central South University, Changsha, Hunan Province 410078, China.
Fengjie Guo
Miao Dai
Di Wang
Yongqing Tong
Jian Huang
Jinyue Hu
Guancheng Li
Central South University · CNWeifang Chinese Medicine Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of tumor-associated antigens, which are specifically expressed in cancer tissues, is very important for immunotherapy of lung cancer. We have combined the in silico screening and experimental verifying to identify genes that are differently expressed in cancers compared with their corresponding normal tissues. Using these methods, we have identified that GABRA3 gene was overexpressed in lung cancer and rarely expressed in other cancers. Furthermore, GABRA3 protein expression was significantly higher in the lower grade of lung cancer. It may compose functional GABA-gated channel with other subunits. This study demonstrated GABRA3 could be a potential biomarker for diagnosis of lung cancer, and GABAA receptors may play an important role in cancer differentiation.

Indexed as

Biomarkers, TumorGene ExpressionGene Expression ProfilingHumansImmunohistochemistryLung NeoplasmsReceptors, GABA-AReverse Transcriptase Polymerase Chain ReactionRNA, MessengerBiomarkers, TumorGABRA3 protein, humanReceptors, GABA-ARNA, Messenger

Identifiers

PMID19048400
OpenAlexW2025572542

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.